Herbas VPB

Print
EN | LT
LT - PREDICTIVE AND PROGNOSTIC BIOMARKERS RELATED TO ANTI-ANGIOGENIC THERAPY OF METASTATIC COLORECTAL CANCER
EN - PREDICTIVE AND PROGNOSTIC BIOMARKERS RELATED TO ANTI-ANGIOGENIC THERAPY OF METASTATIC COLORECTAL CANCER

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. G01N 33/574
European patent
(11) Number of the document 3194974
(13) Kind of document T
(96) European patent application number 15771819.8
Date of filing the European patent application 2015-09-10
(97) Date of publication of the European application 2017-07-26
(45) Date of publication and mention of the grant of the patent 2019-10-23
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/049279
Date 2015-09-10
PCT application publication
(87) Number WO 2016/044041
Date 2016-03-24
Priority applications
(30) Number Date Country code
201462051091 P 2014-09-16 US
201562099630 P 2015-01-05 US
Inventors
(72)
SIMS, Tasha, Nicholle, US
GAO, Bo, US
LOWY, Israel, US
Grantee
(73) Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, US
Title
(54) PREDICTIVE AND PROGNOSTIC BIOMARKERS RELATED TO ANTI-ANGIOGENIC THERAPY OF METASTATIC COLORECTAL CANCER
  PREDICTIVE AND PROGNOSTIC BIOMARKERS RELATED TO ANTI-ANGIOGENIC THERAPY OF METASTATIC COLORECTAL CANCER